Using Gum Arabic for Cancer Patients to Protect From Oral Mucositis Caused by Chemotherapy: ِِِAn Experimental Study
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This study was designed to investigate the effect of Gum Arabic (GA) on cancer patients to
prevent chemotherapy-induced oral mucositis. Cancer patients who will receive chemotherapy
were divided into two groups; study "Gum Arabic" group (which received GA with chemotherapy)
and control group (chemotherapy alone); and the participants were recruited to reach 190
patients in the study group and 184 patients in control group. This clinical trial was
conducted in outpatient chemotherapy sections at Radiation and Isotopes Center of Khartoum.
This study was designed to test the theory that say the chemotherapy-induced oral mucositis
will significantly decrease after ingestion 30 grams as daily dose of Gum Arabic in a form of
solution for six weeks during therapy.